Research / BLKB / Fundamental state Inspectable configuration
State dimensions Filing 0001280058-18-000007 General Corporate
Debt relative to revenue 17th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.debt_to_revenue
55.86% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.29% · OPTIONAL · VALID
Operating cash generation 73th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
22.36% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
7.87% · CORE · NOT_ENOUGH_HISTORY
Gross margin 75th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.gross_margin
54.09% · CORE · VALID
Operating margin 50th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.operating_margin
8.12% · CORE · VALID
R&D intensity 8th Own-history percentile · N=12
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.41% · OPTIONAL · VALID
SBC intensity 83th Own-history percentile · N=12
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
5.15% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 47 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 173.99%
Current 55.86%
Delta -118.13% Capex Intensity Decreased
Previous 1.41%
Current 1.29%
Delta -0.11% Cash Generation Decreased
Previous 35.21%
Current 22.36%
Delta -12.84% Growth Increased
Previous 6.80%
Current 7.87%
Delta 1.07% Margin Decreased
Previous 55.50%
Current 54.09%
Delta -1.41% Profitability Decreased
Previous 9.19%
Current 8.12%
Delta -1.07% R And D Intensity Increased
Previous 11.29%
Current 11.41%
Delta 0.12% Sbc Intensity Decreased
Previous 5.59%
Current 5.15%
Delta -0.43% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.